STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE FORMATION OF THE HUMAN AMPLIFICATION C3-CONVERTASE

被引:151
作者
KAZATCHKINE, MD
FEARON, DT
METCALFE, DD
ROSENBERG, RD
AUSTEN, KF
机构
[1] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
[2] BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02215 USA
[3] ROBERT B BRIGHAM HOSP, DEPT MED, BOSTON, MA 02120 USA
[4] SIDNEY FARBER CANC INST, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1172/JCI110017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:223 / 228
页数:6
相关论文
共 35 条
[1]  
BAKER PJ, 1975, J IMMUNOL, V114, P554
[2]   A MODIFIED URONIC ACID CARBAZOLE REACTION [J].
BITTER, T ;
MUIR, HM .
ANALYTICAL BIOCHEMISTRY, 1962, 4 (04) :330-&
[3]  
BRAI M, 1972, P SOC EXP BIOL MED, V140, P1116
[4]   COMPLEMENT AS A MEDIATOR OF INFLAMMATION .2. BIOLOGICAL PROPERTIES ANAPHYLATOXIN PREPARED WITH PURIFIED COMPONENTS OF HUMAN COMPLEMENT [J].
DASILVA, WD ;
LEPOW, IH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 125 (05) :921-&
[6]   Anticomplementary power of heparin [J].
Ecker, EE ;
Gross, P .
JOURNAL OF INFECTIOUS DISEASES, 1929, 44 :250-253
[7]   PROPERDIN - BINDING TO C3B AND STABILIZATION OF C3B-DEPENDENT C3 CONVERTASE [J].
FEARON, DT ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (04) :856-863
[8]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[9]  
HUNSICKE.LG, 1973, J IMMUNOL, V110, P128
[10]   SELECTIVE N-DESULFATION OF HEPARIN WITH DIMETHYL-SULFOXIDE CONTAINING WATER OR METHANOL [J].
INOUE, Y ;
NAGASAWA, K .
CARBOHYDRATE RESEARCH, 1976, 46 (01) :87-95